The company was founded in 2007 with a registered capital of 956.666.82 million yuan. It is headquartered in Liangli Medical and Health City, Chengdu, Sichuan Province. It is a comprehensive pharmaceutical distribution service provider focusing on the “out-of-hospital market”. The company has always focused on omni-channel pharmaceutical distribution services. Through innovative Internet and big data technology, efficient warehousing and logistics systems, perfect category management, and comprehensive and multi-level services, the company has built an SBBC industrial ecosystem, gradually reduced intermediate circulation links in the out-of-hospital market, and provided convenient, efficient, and low-cost pharmaceutical distribution services for the vast number of community medical terminals and primary medical institutions. Currently, the company operates more than 23,000 kinds of pharmaceutical products, covering Western medicine, proprietary Chinese medicines, Chinese herbal medicines, food and health food, medical devices and non-pharmaceuticals, etc., to fully meet the diverse needs of end customers in the out-of-hospital market. Corporate honors: In 2022, the company was selected as a national e-commerce model enterprise by the Ministry of Commerce of the People's Republic of China; the company was elected as the Secretary General Unit of the MAH Branch of the China Pharmaceutical Finance Association; the company was rated as “Sichuan New Format and New Model Innovative Enterprise” by the Sichuan Provincial Department of Commerce, Sichuan Development and Reform Commission, and the Sichuan Provincial Market Supervision Administration; the company was named “Top 100 Private Enterprises in Chengdu” and “Top 100 Service Enterprises in Chengdu” by the Pharmaceutical Business Branch of the Pharmaceutical Industry Chamber of Commerce of the China Federation of Industry and Commerce.